![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 20, 17928-17932, May 17, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Pharmacogenetics Section, Laboratory of Reproductive and
Developmental Toxicology, National Institute of Environmental Health
Sciences, National Institutes of Health, Research Triangle Park, North
Carolina 27709
Estrogen sulfotransferase (EST) transfers the
sulfate group from 3'-phosphoadenosine 5'-phosphosulfate (PAPS) to
estrogenic steroids. Here we report the crystal structure of human EST
(hEST) in the context of the V269E mutant-PAPS complex, which is the first structure containing the active sulfate donor for any
sulfotransferase. Superimposing this structure with the crystal
structure of hEST in complex with the donor product 3'-phosphoadenosine
5'-phosphate (PAP) and the acceptor substrate 17
Crystal Structure of the Human Estrogen Sulfotransferase-PAPS
Complex
EVIDENCE FOR CATALYTIC ROLE OF Ser137 IN THE
SULFURYL TRANSFER REACTION*
,
,
-estradiol, the
ternary structure with the PAPS and estradiol molecule, is modeled.
These structures have now provided a more complete view of the
SN2-like in-line displacement reaction catalyzed by
sulfotransferases. In the PAPS-bound structure, the side chain nitrogen
of the catalytic Lys47 interacts with the side chain
hydroxyl of Ser137 and not with the bridging oxygen between
the 5'-phosphate and sulfate groups of the PAPS molecule as is seen in
the PAP-bound structures. This conformational change of the side chain
nitrogen indicates that the interaction of Lys47 with
Ser137 may regulate PAPS hydrolysis in the absences of an
acceptor substrate. Supporting the structural data, the mutations of
Ser137 to cysteine and alanine decrease gradually
kcat for PAPS hydrolysis and transfer activity.
Thus, Ser137 appears to play an important role in
regulating the side chain interaction of Lys47 with the
bridging oxygen between the 5'-phosphate and the sulfate of
PAPS.
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Both authors contributed equally to this work.
§
To whom correspondence should be addressed: Pharmacogenetics
Section, Laboratory of Reproductive and Developmental Toxicology, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC 27709. Tel.: 919-541-2404; Fax: 919-541-0696; E-mail: negishi@niehs.nih.gov.
This article has been cited by other articles:
![]() |
H. N. Bethea, D. Xu, J. Liu, and L. C. Pedersen Redirecting the substrate specificity of heparan sulfate 2-O-sulfotransferase by structurally guided mutagenesis PNAS, December 2, 2008; 105(48): 18724 - 18729. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Shi, S. S. Lamb, S. Bhat, T. Sulea, G. D. Wright, A. Matte, and M. Cygler Crystal Structure of StaL, a Glycopeptide Antibiotic Sulfotransferase from Streptomyces toyocaensis J. Biol. Chem., April 27, 2007; 282(17): 13073 - 13086. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Xu, D. Song, L. C. Pedersen, and J. Liu Mutational Study of Heparan Sulfate 2-O-Sulfotransferase and Chondroitin Sulfate 2-O-Sulfotransferase J. Biol. Chem., March 16, 2007; 282(11): 8356 - 8367. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Gamage, A. Barnett, N. Hempel, R. G. Duggleby, K. F. Windmill, J. L. Martin, and M. E. McManus Human Sulfotransferases and Their Role in Chemical Metabolism Toxicol. Sci., March 1, 2006; 90(1): 5 - 22. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. U. Gamage, S. Tsvetanov, R. G. Duggleby, M. E. McManus, and J. L. Martin The Structure of Human SULT1A1 Crystallized with Estradiol: AN INSIGHT INTO ACTIVE SITE PLASTICITY AND SUBSTRATE INHIBITION WITH MULTI-RING SUBSTRATES J. Biol. Chem., December 16, 2005; 280(50): 41482 - 41486. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Chen, K. Ichihara-Tanaka, and T. Muramatsu Role of the Carboxyl-Terminal Region in the Activity of N-Acetylglucosamine 6-O-Sulfotransferase-1 J. Biochem., November 1, 2004; 136(5): 659 - 664. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Moon, S. C. Edavettal, J. M. Krahn, E. M. Munoz, M. Negishi, R. J. Linhardt, J. Liu, and L. C. Pedersen Structural Analysis of the Sulfotransferase (3-O-Sulfotransferase Isoform 3) Involved in the Biosynthesis of an Entry Receptor for Herpes Simplex Virus 1 J. Biol. Chem., October 22, 2004; 279(43): 45185 - 45193. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Edavettal, K. A. Lee, M. Negishi, R. J. Linhardt, J. Liu, and L. C. Pedersen Crystal Structure and Mutational Analysis of Heparan Sulfate 3-O-Sulfotransferase Isoform 1 J. Biol. Chem., June 11, 2004; 279(24): 25789 - 25797. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Sheng, A. Saxena, and M. W. Duffel INFLUENCE OF PHENYLALANINES 77 AND 138 ON THE STEREOSPECIFICITY OF ARYL SULFOTRANSFERASE IV Drug Metab. Dispos., May 1, 2004; 32(5): 559 - 565. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Barnett, S. Tsvetanov, N. Gamage, J. L. Martin, R. G. Duggleby, and M. E. McManus Active Site Mutations and Substrate Inhibition in Human Sulfotransferase 1A1 and 1A3 J. Biol. Chem., April 30, 2004; 279(18): 18799 - 18805. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Pi, Y. Yu, J. D. Mougous, and J. A. Leary Observation of a hybrid random ping-pong mechanism of catalysis for NodST: A mass spectrometry approach Protein Sci., April 1, 2004; 13(4): 903 - 912. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Lee, H. Fuda, Y. C. Lee, M. Negishi, C. A. Strott, and L. C. Pedersen Crystal Structure of Human Cholesterol Sulfotransferase (SULT2B1b) in the Presence of Pregnenolone and 3'-Phosphoadenosine 5'-Phosphate: RATIONALE FOR SPECIFICITY DIFFERENCES BETWEEN PROTOTYPICAL SULT2A1 AND THE SULT2B1 ISOFORMS J. Biol. Chem., November 7, 2003; 278(45): 44593 - 44599. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Chen and X. Chen Arginine Residues in the Active Site of Human Phenol Sulfotransferase (SULT1A1) J. Biol. Chem., September 19, 2003; 278(38): 36358 - 36364. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R. Tulik, S. Chodavarapu, R. Edgar, L. Giannunzio, A. Langland, B. Schultz, and J. D. Beckmann Inhibition of Bovine Phenol Sulfotransferase (bSULT1A1) by CoA Thioesters. EVIDENCE FOR POSITIVE COOPERATIVITY AND INHIBITION BY INTERACTION WITH BOTH THE NUCLEOTIDE AND PHENOL BINDING SITES J. Biol. Chem., October 11, 2002; 277(42): 39296 - 39303. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Strott Sulfonation and Molecular Action Endocr. Rev., October 1, 2002; 23(5): 703 - 732. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Fuda, Y. C. Lee, C. Shimizu, N. B. Javitt, and C. A. Strott Mutational Analysis of Human Hydroxysteroid Sulfotransferase SULT2B1 Isoforms Reveals That Exon 1B of the SULT2B1 Gene Produces Cholesterol Sulfotransferase, whereas Exon 1A Yields Pregnenolone Sulfotransferase J. Biol. Chem., September 20, 2002; 277(39): 36161 - 36166. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |